Filing Details
- Accession Number:
- 0001144204-14-016263
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-03-17 21:31:12
- Reporting Period:
- 2014-03-13
- Filing Date:
- 2014-03-17
- Accepted Time:
- 2014-03-17 21:31:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1117480 | Chimerix Inc | CMRX | Pharmaceutical Preparations (2834) | 330903395 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1070009 | I Kenneth Moch | C/O Chimerix, Inc. 2505 Meridian Parkway, Suite 340 Durham NC 27713 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-03-13 | 15,000 | $1.57 | 20,292 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-03-13 | 18,979 | $25.00 | 1,313 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2014-03-13 | 15,000 | $0.00 | 15,000 | $1.57 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
200,352 | 2019-06-19 | No | 4 | M | Direct |
Footnotes
- Includes 1,313 shares acquired under the Issuer's 2013 Employee Stock Purchase Plan on March 10, 2014.
- The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2013.
- 64,020 shares became exercisable on June 8, 2009, 1,707 shares became exercisable on August 8, 2010, and the remaining 159,625 shares subject to the option vested and become exercisable in equal monthly installments thereafter.